ABBOTT LABORATORIES (ABL.DE) Stock Price, Quote, News and Overview
FRA:ABL - Deutsche Boerse Ag - US0028241000 - Common Stock - Currency: EUR
ABL.DE Quote, Performance and Key Statistics
ABBOTT LABORATORIES
FRA:ABL (1/22/2025, 7:00:00 PM)
114.34
+2.86 (+2.57%)
The current stock price of ABL.DE is 114.34 EUR. In the past month the price increased by 5.09%. In the past year, price increased by 10.79%.
ABL.DE Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| IUI1.DE | INTUITIVE SURGICAL INC | 91.65 | 209.90B | ||
| 1ISRG.MI | INTUITIVE SURGICAL INC | 89.78 | 205.62B | ||
| BSX.DE | BOSTON SCIENTIFIC CORP | 43.14 | 143.70B | ||
| 2M6.DE | MEDTRONIC PLC | 16.84 | 108.61B | ||
| 1MDT.MI | MEDTRONIC PLC | 16.67 | 107.51B | ||
| BOX.DE | BECTON DICKINSON AND CO | 18.21 | 66.56B | ||
| SHL.DE | SIEMENS HEALTHINEERS AG | 24.37 | 61.30B | ||
| EWL.DE | EDWARDS LIFESCIENCES CORP | 26.12 | 39.43B | ||
| DC4.DE | DEXCOM INC | 51.69 | 32.91B | ||
| PHIA.AS | KONINKLIJKE PHILIPS NV | 19.86 | 24.08B | ||
| PHI1.DE | KONINKLIJKE PHILIPS NV | 19.77 | 23.97B | ||
| 1PHIA.MI | KONINKLIJKE PHILIPS NV | 19.42 | 23.55B |
Related screens
About ABL.DE
Company Profile
Abbott Laboratories engages in the discovery, development, manufacture, and sale of health care products. The company is headquartered in Abbott Park, Illinois and currently employs 114,000 full-time employees. The firm is engaged in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. The firm operates through four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment is engaged in the international sales of a broad line of branded generic pharmaceutical products. The Diagnostic Products segment is engaged in the worldwide sales of diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Nutritional Products segment is involved in the worldwide sales of a broad line of adult and pediatric nutritional products. The Medical Devices segment includes the worldwide sales of rhythm management, electrophysiology, heart failure, vascular, structural heart, neuromodulation, and diabetes care products.
Company Info
ABBOTT LABORATORIES
100 Abbott Park Road, Abbot Park
ABBOTT PARK ILLINOIS US
Employees: 114000
Company Website: https://www.abbott.com
Investor Relations: https://www.abbott.com/investors.html
Phone: 12246676100
ABL.DE FAQ
What is the price of ABL.DE?
The current price of ABL.DE is 114.34 EUR.
What is the symbol for ABBOTT LABORATORIES?
The exchange symbol of ABBOTT LABORATORIES is ABL and it is listed on the Deutsche Boerse Ag exchange.
On which exchange is ABL.DE listed?
ABL.DE is listed on the Deutsche Boerse Ag exchange.
Is ABL.DE a good stock to buy?
Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for ABL.DE, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of ABL.DE.
Does ABL.DE pay dividends?
ABL.DE has a dividend yield of 2.07%. The yearly dividend amount is currently 2.05.
When does ABL.DE report earnings?
ABL.DE will report earnings on 2025-01-22, before the market open.
What is the Price/Earnings (PE) ratio of ABL.DE?
The PE ratio for ABL.DE is 26.41. This is based on the reported non-GAAP earnings per share of 4.33 and the current share price of 114.34 EUR.
ABL.DE Technical Analysis
ChartMill assigns a technical rating of 6 / 10 to ABL.DE. When comparing the yearly performance of all stocks, ABL.DE turns out to be only a medium performer in the overall market: it outperformed 64.9% of all stocks.
ABL.DE Fundamental Analysis
ChartMill assigns a fundamental rating of 6 / 10 to ABL.DE. ABL.DE scores excellent points on both the profitability and health parts. This is a solid base for a good stock.
ABL.DE Financial Highlights
Over the last trailing twelve months ABL.DE reported a non-GAAP Earnings per Share(EPS) of 4.33. The EPS increased by 5.61% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 13.99% | ||
| ROA | 7.76% | ||
| ROE | 14.49% | ||
| Debt/Equity | 0.32 |
ABL.DE Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 81% to ABL.DE. The Buy consensus is the average rating of analysts ratings from 32 analysts.
For the next year, analysts expect an EPS growth of 6.36% and a revenue growth 4.76% for ABL.DE